Copy
Dr. Daniel Margolis will be at our conference in September!
View this email in your browser

Dr. Margolis at our Conference!

We are thrilled to have Dr. Daniel Margolis of UCLA at our conference this year! He will be speaking on the use of advanced magnetic resonance imaging (MRI) in prostate cancer diagnostics. Dr. Margolis is a leading expert in the use of medical imaging as a non-invasive "surrogate" biomarker for cancer therapy development.

Under Dr. Margolis' supervision, the prostate imaging program at UCLA has performed over 400 prostate MRI studies each year for various purposes, from biopsy guidance to pre-surgical staging and radiotherapy planning. His department is also at the forefront of MRI technology, being the first to demonstrate dynamic contrast MRI of the prostate. Findings from Dr. Margolis' research have been presented at national and international meetings and published in many journals.

As the Associate Professor of Radiology, Dr. Margolis lectures on the use of advanced techniques for prostate and renal imaging at the UCLA David Geffen School of Medicine. He also speaks at notable urological meetings such as UCLA's Annual State-of-the-Art Urology Conference.

Don’t miss Dr. Daniel Margolis on Saturday, September 12, as well as many other esteemed prostate cancer experts covering a wide variety of topics including; Chemotherapy, Xofigo, Bone Health, Immunotherapy, Seed Implant Radiation, and many more.

Register online at pcri.org or call our team at (310) 743-2116. We look forward to seeing you there!

Active Surveillance Banner

Active Surveillance Videos

Be sure to check out these short clips from healthcare professionals, caregivers, and most importantly, patients and their families about the benefits of active surveillance. It is no secret that PCRI has been a strong advocate of active surveillance for Low-Risk prostate cancer, especially with the advance of sophisticated imaging and genetic diagnostic tools. Different clinical studies have shown the benefit of this non-invasive cautious monitoring approach to avoid over-treatment and protect quality of life.


Watch and share these videos to help us spread the message that under careful surveillance, many men with prostate cancer can benefit, not from treatment, but from no treatment.

Facebook
Twitter
Website
Email
YouTube
Copyright © 2015 Prostate Cancer Research Institute, All rights reserved.


unsubscribe from this list    update subscription preferences